This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III StudyCDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III Study
PCI Directs Examining Authorities to Mandatorily Register on Portal by Feb 21PCI Releases Draft Pharmacist Service Rules 2025, Proposes Unified National Cadre
DoP Invites Applications for Young Professionals Across Key Divisions, Offers Rs 50,000 Monthly PayDoP Invites Applications for Young Professionals Across Key Divisions, Offers Rs 50,000 Monthly Pay
Coldrif case: ED attaches assets worth over Rs 2 crore of Sresan Pharma proprietorColdrif case: ED attaches assets worth over Rs 2 crore of Sresan Pharma proprietor
Lupin signs licensing pact with Gan & Lee Pharma for GLP-1 receptor agonist BofanglutideLupin enters into licensing agreement with Valorum for biosimilar Armlupeg in US
ZydusUSFDA issues EIR for Zydus Jarod injectable facility
Granules India packaging facility in US successfully completes USFDA inspectionGranules India packaging facility in US successfully completes USFDA inspection
USFDA-Telangana DCA meet to discuss future activitiesUSFDA-Telangana DCA meet to discuss future activities
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boomEli Lilly Jaypirca secures USFDA approval for adults with relapsed or refractory CLL/SLL previously...
Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 millionSandoz unveils denosumab biosimilars in Europe
Gurgaon Health Dept Bans Mifepristone-Misoprostol Sales, Warns Chemists of Penal ActionOdisha ramps up drive against illegal sale of MTP kits
Lupin Launches Epilepsy, Migraine Drug Topiramate XR in US, Targets USD 164 Million MarketLupin Eyes Rs 11,800 Crore Vitabiotics Buyout, Lalvani Family-Owned Brand in Focus
X